India Today on MSN
How to lose 14 kg in 3 months? Nutritionist shares diet plan
Losing 14 kg in three months may sound ambitious, but experts say it can be possible with the right combination of diet, ...
The widely followed Standard & Poor’s 500 Index is the standard by which stock market performance in the U.S. is often measured, as it tracks 500 of the largest and most stable publicly traded ...
Kane Footwear's CEO John Gagliardi talks recovery market, the new open-back shoe, and an update on the firm's business.
World Obesity Atlas 2026 reports India ranks second globally in childhood obesity burden, with projections showing rising BMI-related metabolic risks by 2040.
NFL Combine measurements results 2026: Hand size, height, weight and more for Fernando Mendoza, other notables originally appeared on The Sporting News. Add The Sporting News as a Preferred Source by ...
Background News media have reported that the average height of British children is falling, but these reports have been ...
With the S&P 500 posting record highs, wealth managers are rethinking the wisdom behind buying the index for client portfolios. The index has increased 256% since 2016, driven recently by an ...
December’s raw materials bill topped $2 billion for the first time since August 2023 and surging lithium, nickel prices going into 2026 puts battery metals slump definitively in the rearview mirror.
ALLEROD, Denmark, Jan 30 (Reuters) - A play examining the meteoric rise of Danish weight-loss drug giant Novo Nordisk (NOVOb.CO), opens new tab will premiere on Saturday at a theatre outside ...
FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, December 3, 2025. REUTERS/Tom Little/File Photo ...
Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) who receive long-term methylphenidate treatment face increased risks for overweight or ...
Novo Nordisk has had a difficult year as investors questioned the company's ability to translate its strides in pioneering GLP-1 drugs to financial gains. Scientists, however, say that Novo's medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results